Primary myelofibrosis: older age and high JAK2 V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease

Highlights • We have measured plasma levels of hs-CRP in 526 subjects with PMF. • 38% of subjects with PMF had elevated hs-CRP. • Age ≥ 52 years and JAK2 V617F mutation with ≥ 50% allele burden were independently associated with elevated hs-CRP. • Older age and high allele burden JAK2 V617F mutation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia research 2017
Hauptverfasser: Barosi, Giovanni, Massa, Margherita, Campanelli, Rita, Fois, Gabriela, Catarsi, Paolo, Viarengo, Gianluca, Villani, Laura, Poletto, Valentina, Bosoni, Tiziana, Magrini, Umberto, Gale, Robert P, Rosti, Vittorio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • We have measured plasma levels of hs-CRP in 526 subjects with PMF. • 38% of subjects with PMF had elevated hs-CRP. • Age ≥ 52 years and JAK2 V617F mutation with ≥ 50% allele burden were independently associated with elevated hs-CRP. • Older age and high allele burden JAK2 V617F mutation were also associated with a phenotype of progressive disease. • We interpreted our finding as reflecting an intrinsic inflammatory pathway promoted by older age and high allele burden JAK2 V617F
ISSN:0145-2126
DOI:10.1016/j.leukres.2017.06.004